Metraipolis › archive › dc_a4cabc4e0e2f

Tocilizumab as a novel bridging therapy for surgery in dedifferentiated liposarcoma complicated by paraneoplastic leukemoid reaction, severe anemia, and… — Europe PMC PMID:42164115

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42164115
DOI
10.3389/fonc.2026.1762067
License (as archived)
solo-consultazione
Archived
2026-11-02T18:39:28.033Z
SHA-256 of the archived text
8bb53d0ea198acb4032fcdbe03f1aece26ff54ee3ba939e6c290880f96191c85
Stable URL of this page
https://metraipolis.com/documento/dc_a4cabc4e0e2f

How to cite

Tocilizumab as a novel bridging therapy for surgery in dedifferentiated liposarcoma complicated by paraneoplastic leukemoid reaction, severe anemia, and… — Europe PMC PMID:42164115 — Europe PMC (en), https://europepmc.org/article/MED/42164115 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a4cabc4e0e2f (Metraipolis archive dc_a4cabc4e0e2f, sha256 8bb53d0ea198acb4032fcdbe03f1aece26ff54ee3ba939e6c290880f96191c85)
BibTeX
@misc{dca4cabc4e0e2f,
  title = {Tocilizumab as a novel bridging therapy for surgery in dedifferentiated liposarcoma complicated by paraneoplastic leukemoid reaction, severe anemia, and… — Europe PMC PMID:42164115},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42164115},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a4cabc4e0e2f; sha256 8bb53d0ea198acb4032fcdbe03f1aece26ff54ee3ba939e6c290880f96191c85},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42164115. Agents can read the archived copy with the MCP tool read_document.